GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » Return-on-Tangible-Asset

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Return-on-Tangible-Asset : -42.79% (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Creative Medical Technology Holdings's annualized Net Income for the quarter that ended in Mar. 2024 was $-4.17 Mil. Creative Medical Technology Holdings's average total tangible assets for the quarter that ended in Mar. 2024 was $9.74 Mil. Therefore, Creative Medical Technology Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was -42.79%.

The historical rank and industry rank for Creative Medical Technology Holdings's Return-on-Tangible-Asset or its related term are showing as below:

CELZ' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -37838.54   Med: -2507.92   Max: 354.53
Current: -43.91

During the past 13 years, Creative Medical Technology Holdings's highest Return-on-Tangible-Asset was 354.53%. The lowest was -37838.54%. And the median was -2507.92%.

CELZ's Return-on-Tangible-Asset is ranked worse than
53.31% of 1555 companies
in the Biotechnology industry
Industry Median: -39.47 vs CELZ: -43.91

Creative Medical Technology Holdings Return-on-Tangible-Asset Historical Data

The historical data trend for Creative Medical Technology Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Return-on-Tangible-Asset Chart

Creative Medical Technology Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,169.04 -37,838.54 354.53 -68.80 -36.43

Creative Medical Technology Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.07 -30.88 -45.11 -60.18 -42.79

Competitive Comparison of Creative Medical Technology Holdings's Return-on-Tangible-Asset

For the Biotechnology subindustry, Creative Medical Technology Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creative Medical Technology Holdings's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's Return-on-Tangible-Asset falls into.



Creative Medical Technology Holdings Return-on-Tangible-Asset Calculation

Creative Medical Technology Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-5.287/( (18.75+10.274)/ 2 )
=-5.287/14.512
=-36.43 %

Creative Medical Technology Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-4.168/( (10.274+9.208)/ 2 )
=-4.168/9.741
=-42.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Creative Medical Technology Holdings  (NAS:CELZ) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Creative Medical Technology Holdings Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Medical Technology Holdings (Creative Medical Technology Holdings) Business Description

Traded in Other Exchanges
N/A
Address
211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Executives
Timothy Warbington director, 10 percent owner, officer: President & CEO 211 E. OSBORN ROAD, PHOENIX AZ 85012
Michael H. Finger director 1551 N. DIANE ST., MESA AZ 85203-3850
Susan H Snow director 26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang director 5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim director 211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc. 10 percent owner 211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst 10 percent owner 2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel director 1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson director, officer: CFO & Sr.VP 822 VERA STREET, SOLANA BEACH CA 92075
Steven L White director, officer: President,Secretary,Treasurer 386 NORTH 210 EAST, MAPLETON UT 84664

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Headlines

From GuruFocus

Creative Medical Technology Holdings Provides Corporate Update

By PRNewswire PRNewswire 06-12-2023